| Status | In progress |
| Process | STA 2018 |
| ID number | 3831 |
Provisional Schedule
| Committee meeting | 13 October 2021 |
| Expected publication | 05 January 2022 |
Project Team
| Project lead | Louise Jafferally |
Email enquiries
- If you have any queries please email TATeam4@nice.org.uk
| Evidence Review Group / Assessment Group | Kleijnen Systematic Reviews Ltd |
Consultees
| Companies sponsors | Amarin Corporation (Icosapent ethyl) |
| Others | Department for Health and Social Care |
| NHS England | |
| NHS Nottingham City CCG | |
| NHS Southwark CCG | |
| Welsh Government | |
| Patient carer groups | Arrythmia Alliance |
| Atrial Fibrillation Association | |
| Blood Pressure UK | |
| Cardiac Risk in the Young | |
| Cardiomyopathy UK | |
| Cardiovascular Care Partnership | |
| Circulation Foundation | |
| Different Strokes | |
| Genetic Alliance | |
| HEART UK | |
| Network of Sikh Organisations | |
| Pumping Marvellous Foundation | |
| Somerville Foundation | |
| South Asian Health Foundation | |
| Specialised Healthcare Alliance | |
| Stroke Association | |
| Stroke Information | |
| Professional groups | Association of Genetic Nurses and Counsellors |
| British Association for Nursing in Cardiovascular Care | |
| British Association of Stroke Physicians | |
| British Atherosclerosis Society | |
| British Cardiovascular Intervention Society | |
| British Cardiovascular Society | |
| British Geriatrics Society | |
| British Heart Foundation | |
| British Heart Rhythm Society | |
| British Nuclear Cardiology Society | |
| British Society for Gene and Cell Therapy | |
| British Society for Genetic Medicine | |
| British Society for Haematology | |
| British Society for Haemostasis and Thrombosis | |
| British Society for Heart Failure | |
| British Society for Human Genetics | |
| British Society of Cardiovascular Imaging | |
| Clinical Leaders of Thrombosis | |
| National Heart and Lung Institute | |
| Royal College of Emergency Medicine | |
| Royal College of General Practitioners | |
| Royal College of Nursing | |
| Royal College of Pathologists | |
| Royal College of Physicians | |
| Royal Pharmaceutical Society | |
| Royal Society of Medicine | |
| Society for Cardiological Science and Technology | |
| Society for Vascular Nurses | |
| Society for Vascular Technology | |
| UK Clinical Pharmacy Association | |
| UK Genetic Testing Network | |
| Vascular Society of Great Britain and Ireland |
Commentators
| Associated guideline groups | National Guideline Alliance |
| Associated public health groups | Public Health England |
| Public Health Wales | |
| Comparator companies | None |
| General commentators | All Wales Therapeutics and Toxicology Centre |
| Allied Health Professionals Federation | |
| Board of Community Health Councils in Wales | |
| British National Formulary | |
| Care Quality Commission | |
| Department of Health, Social Services and Public Safety for Northern Ireland | |
| Healthcare Improvement Scotland | |
| Medicines and Healthcare Products Regulatory Agency | |
| National Association of Primary Care | |
| National Pharmacy Association | |
| NHS Alliance | |
| NHS Confederation | |
| Scottish Medicines Consortium | |
| Welsh Health Specialised Services Committee | |
| Relevant research groups | British Society for Cardiovascular Research |
| Cardiac and Cardiology Research Dept, Barts | |
| Cochrane Heart Group | |
| Cochrane Stroke Group | |
| Cochrane Vascular | |
| European Council for Cardiovascular Research | |
| MRC Clinical Trials Unit | |
| National Centre for Cardiovascular Prevention and Outcomes | |
| Heart Research UK | |
| National Institute for Health Research | |
| Society for Research in Rehabilitation | |
| Wellcome Trust |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 15 February 2021 | Invitation to participate |
| 15 February 2021 | In progress. In progress. |
| 25 September 2020 - 23 October 2020 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance